Skip to main content
KORU Medical Systems, Inc. logo

KORU Medical Systems, Inc. — Investor Relations & Filings

Ticker · KRMD ISIN · US7599101026 US Manufacturing
Open in API
Filings indexed 922 across all filing types
Latest filing 2025-03-17 Regulatory Filings
Country US United States of America
Listing US KRMD

About KORU Medical Systems, Inc.

https://www.korumedical.com/

KORU Medical Systems is a medical technology company that designs, develops, manufactures, and commercializes subcutaneous infusion solutions. The company's primary offering is the Freedom™ Infusion System, which includes syringe infusion pumps and related accessories. These systems are engineered for the delivery of large-volume subcutaneous drugs, such as immunoglobulins, to treat patients with chronic illnesses. KORU Medical Systems focuses on providing patient-centric solutions that facilitate safe and effective home-based infusion therapy, aiming to enhance patient quality of life by offering greater freedom and flexibility in treatment management.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2025
Regulatory Filings
2025-03-17 English
POST-EFFECTIVE AMENDMENT NO. 1 TO REGISTRATION STATEMENT ON FORM S-8
Transaction in Own Shares Classification · 95% confidence The document is a Post-Effective Amendment No. 1 to a Registration Statement on Form S-8 filed with the SEC. Form S-8 is used for registering securities to be offered under employee benefit plans, such as stock options. The document discusses deregistering unissued and unsold shares related to a stock option award. It is a regulatory filing related to securities registration and amendments, not a financial report, earnings release, or management discussion. The document is relatively short (4484 characters) and is a formal SEC filing amending a prior registration statement. Therefore, the appropriate classification is Transaction in Own Shares (POS), as it relates to stock option awards and deregistration of shares under such plans.
2025-03-12 English
FORM S-8 REGISTRATION STATEMENT
Capital/Financing Update Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used to register securities to be offered under employee benefit plans, such as stock options. It includes detailed information about the securities being registered, indemnification provisions, incorporation by reference of other filings, and exhibits related to the registration. It is not an annual report, earnings release, or any other financial report but a registration statement related to capital raising through stock options. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial and contains the full registration statement, not just an announcement or certification.
2025-03-12 English
FORM 10-K ANNUAL REPORT FOR 12-31-2024
Annual Report FY 2024
2025-03-12 English
FORM 8-K CURRENT REPORT FOR 03-12-2025
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated March 12, 2025, reporting the company's financial results for the fourth quarter and full year ended December 31, 2024, along with financial guidance for 2025. It includes a press release as an exhibit and mentions a related conference call. The document is a current report announcing earnings results, not the full earnings release itself or a detailed quarterly/interim report. The key section is ITEM 2.02, which is typically used for earnings announcements. The document length is 6460 characters, which is consistent with a Form 8-K earnings release announcement. Therefore, the filing type corresponds to an Earnings Release (ER).
2025-03-12 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-02-14 English

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.